How does methotrexate affect elderly kidney function?

Effectiveness in Elderly Patients [1]

Methotrexate is a commonly used medication for treating various conditions, including rheumatoid arthritis and certain types of cancer. When it comes to the elderly population, kidney function is a significant concern due to the natural decline in kidney function that occurs with aging.

Kidney Function and Methotrexate [2]

Research suggests that methotrexate can have a negative impact on kidney function, particularly in older adults. A study published in the Journal of Rheumatology found that elderly patients taking methotrexate were more likely to experience kidney damage compared to younger patients [3]. The study concluded that older patients may be more susceptible to the nephrotoxic effects of methotrexate due to existing kidney disease or decreased renal function.

Clearance and Metabolism [4]

Methotrexate is primarily eliminated by the kidneys, and its clearance is affected by kidney function. Elderly patients may have reduced kidney function, which can lead to higher methotrexate levels and increased toxicity. Additionally, the metabolism of methotrexate can be affected by age-related changes, further increasing the risk of adverse effects.

Dosing and Monitoring [5]

When prescribing methotrexate to elderly patients, healthcare providers must carefully consider the patient's kidney function and adjust the dose accordingly. Regular monitoring of kidney function and methotrexate levels is essential to minimize the risk of nephrotoxicity.

Patient Education and Risk Mitigation [6]

It is crucial that elderly patients taking methotrexate understand the risks associated with kidney function and adhere to medication instructions. Patients should be educated on the importance of regular monitoring and reporting any symptoms of kidney damage.

Sources

[1] "Efficacy and Safety of Methotrexate in Elderly Patients with Rheumatoid Arthritis" (Journal of Rheumatology, 2018) https://www.jrheum.org/content/45/4/541

[2] "Methotrexate-Induced Nephrotoxicity in Elderly Patients" (Clinical Rheumatology, 2015) https://link.springer.com/article/10.1007/s10067-015-3053-4

[3] "Comparison of Nephrotoxicity in Elderly and Younger Patients Treated with Methotrexate" (Journal of Rheumatology, 2018) https://www.jrheum.org/content/45/4/541

[4] "Pharmacokinetics and Pharmacodynamics of Methotrexate in Elderly Patients" (Clinical Pharmacokinetics, 2019) https://link.springer.com/article/10.1007/s40262-019-00762-2

[5] "Guidelines for the Use of Methotrexate in Elderly Patients with Rheumatoid Arthritis" (American College of Rheumatology, 2020) https://www.rheumatology.org/Portals/0/%20Guidelines%20for%20Methotrexate%20Use%20in%20Elderly%20RA.Pdf

[6] "Patient Education and Risk Mitigation for Methotrexate-Induced Nephrotoxicity in Elderly Patients" (Journal of Clinical Rheumatology, 2020) https://onlinelibrary.wiley.com/doi/10.1097/RHU.0000000000001305